癌症治疗的突出超分子系统:从结构设计到定制应用
Jiawei Zhang1, Qingya Zhang2, Xiaojia Li3
1The First Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, China; School of Intelligent Medicine, China Medical University, No.77, Puhe Road, Shenyang, China.
European journal of medicinal chemistry
|May 16, 2025
概括
高分子材料为癌症诊断和治疗提供了先进的解决方案. 这篇评论强调了Pillarene系统,病毒模拟纳米粒子和精密瘤学的金属有机框架.
科学领域:
- 超分子化学 超分子化学
- 纳米医学是一种纳米医学.
- 在瘤学瘤学.
背景情况:
- 超分子材料具有动态架构,刺激响应能力和高生物相容性,这使得它们对癌症诊断和治疗具有前景.
- 关键的超分子类别包括基于Pillarene的系统,病毒模拟纳米粒子 (VMNs) 和金属有机框架 (MOF).
- 还讨论了其他相关的超分子平台,如环极和树枝状体.
研究的目的:
- 对癌症纳米医学进行代表性的超分子系统的审查和分析.
- 突出Pillarene组件,VMN和MOF的独特结构和功能特性.
- 为设计用于精密瘤学的先进超分子系统提供框架.
主要方法:
- 文献审查,重点关注基于Pillarene的系统,VMN和MOF在癌症应用中的应用.
- 讨论制造,药物加载,控制释放和准能力.
- 与传统的纳米载体进行比较分析,并对药物动力学和生物安全方面的评估.
主要成果:
- 柱体组件提供精确的宿主-客人相互作用,以提供强大的药物输送.
- 由于它们的病毒结构,VMN在向癌细胞和透膜方面表现出色.
- MOFs在多模式癌症诊断和治疗中显示出潜力.
结论:
- 超分子纳米药物,包括Pillarene系统,VMN和MOF,为癌症治疗提供适应性,向性和多功能策略.
- 对药物动力学行为和生物安全的批判性评估对于转化成功至关重要.
- 这些先进的纳米技术对重塑精密瘤学具有重大前景.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


